Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
46.00
46.90
39.69
54.94
62.38
63.21
63.83
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
46.00
46.90
39.69
54.94
62.38
63.21
63.83
Raw Material Cost
15.81
12.16
12.93
12.86
16.80
16.41
18.09
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.82
3.66
3.45
4.44
0.14
0.45
0.05
Selling and Distribution Expenses
38.78
28.87
47.26
35.30
43.58
35.84
49.67
Other Expenses
1.25
0.72
2.21
0.61
2.78
1.40
2.66
Total Expenditure (Excl Depreciation)
70.87
51.87
85.77
58.69
88.37
66.71
94.38
Operating Profit (PBDIT) excl Other Income
-24.900000000000002
-5
-46.1
-3.7
-26
-3.5
-30.6
Other Income
0.60
0.76
1.33
0.86
2.09
1.08
6.34
Operating Profit (PBDIT)
-18.86
1.08
-41.26
1.61
-18.38
2.36
-21.11
Interest
3.82
3.66
3.45
4.44
0.14
0.45
0.05
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
30.19
34.73
26.77
42.08
45.58
46.81
45.74
Depreciation
6.90
6.90
5.87
5.87
6.27
6.27
3.52
Profit Before Tax
-29.58
-9.47
-50.59
-8.70
-24.79
-4.36
-24.67
Tax
0.00
-0.00
-0.30
0.00
0.08
0.00
113.41
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-28.34
-8.43
-47.07
-6.05
-22.30
-2.34
-135.48
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-28.34
-8.43
-47.07
-6.05
-22.30
-2.34
-135.48
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-1.24
-0.85
-3.15
-2.59
-2.53
-2.07
-2.89
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-29.58
-9.28
-50.23
-8.64
-24.83
-4.41
-138.37
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
807.18
809.82
820.78
870.61
1,047.30
953.43
929.23
Earnings per share (EPS)
-0.06
-0.02
-0.1
-0.01
-0.05
-0.0
-0.28
Diluted Earnings per share
-0.06
-0.02
-0.1
-0.01
-0.05
-0.0
-0.28
Operating Profit Margin (Excl OI)
-57.31%
-14.02%
-122.09%
-9.32%
-42.85%
-7.89%
-48.51%
Gross Profit Margin
-49.3%
-5.49%
-112.65%
-5.15%
-29.69%
3.02%
-33.14%
PAT Margin
-61.6%
-17.98%
-118.59%
-11.02%
-35.75%
-3.69%
-212.25%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is -26.28% vs -27.86% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is -19.35% vs -8,366.67% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 4.88% vs -430.65% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is 3,700.00% vs -66.67% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Compare Quarterly Results Of Staidson (Beijing) Biopharmaceuticals Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
46.00
0
46.00
Other Operating Income
0.00
0.00
0.00
Total Operating income
46.00
0
46.00
Raw Material Cost
15.81
0
15.81
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
3.82
0
3.82
Selling and Distribution Expenses
38.78
0
38.78
Other Expenses
1.25
0.00
1.25
Total Expenditure (Excl Depreciation)
70.87
0
70.87
Operating Profit (PBDIT) excl Other Income
-24.87
0.00
-24.87
Other Income
0.60
0
0.60
Operating Profit (PBDIT)
-18.86
0
-18.86
Interest
3.82
0
3.82
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
30.19
0
30.19
Depreciation
6.90
0
6.90
Profit Before Tax
-29.58
0
-29.58
Tax
0.00
0
0.00
Provisions and contingencies
0
0
0.00
Profit After Tax
-28.34
0
-28.34
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-28.34
0
-28.34
Share in Profit of Associates
0
0
0.00
Minority Interest
-1.24
0
-1.24
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-29.58
0
-29.58
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
807.18
0
807.18
Earnings per share (EPS)
-0.06
0
-0.06
Diluted Earnings per share
-0.06
0
-0.06
Operating Profit Margin (Excl OI)
-57.31%
0%
0.00
-57.31%
Gross Profit Margin
-49.30%
0%
0.00
-49.30%
PAT Margin
-61.60%
0%
0.00
-61.60%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 4.60 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -1.92% vs 18.14% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -26.28% vs -27.86% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit -2.96 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -218.28% vs 81.47% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -19.35% vs -8,366.67% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -1.95 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -6,600.00% vs 100.70% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 4.88% vs -430.65% in Jun 2025
Quarterly - Interest
Interest 0.38 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 2.70% vs 5.71% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 3,700.00% vs -66.67% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -57.31%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Footer loading
